Respiratory syncytial, parainfluenza and influenza virus infection in young children with acute lower respiratory infection in rural Gambia.
Child, Preschool
Female
Gambia
/ epidemiology
Humans
Incidence
Infant
Influenza A virus
/ isolation & purification
Influenza, Human
/ diagnosis
Male
Paramyxoviridae
/ isolation & purification
Paramyxoviridae Infections
/ diagnosis
Population Surveillance
Respiratory Syncytial Virus Infections
/ diagnosis
Respiratory Syncytial Viruses
/ isolation & purification
Respiratory Tract Infections
/ diagnosis
Rural Population
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
29 11 2019
29 11 2019
Historique:
received:
23
11
2018
accepted:
23
08
2019
entrez:
1
12
2019
pubmed:
1
12
2019
medline:
11
11
2020
Statut:
epublish
Résumé
Respiratory viral infections contribute significantly to morbidity and mortality worldwide, but representative data from sub-Saharan Africa are needed to inform vaccination strategies. We conducted population-based surveillance in rural Gambia using standardized criteria to identify and investigate children with acute lower respiratory infection (ALRI). Naso- and oropharyngeal swabs were collected. Each month from February through December 2015, specimens from 50 children aged 2-23 months were randomly selected to test for respiratory syncytial (RSV), parainfluenza (PIV) and influenza viruses. The expected number of viral-associated ALRI cases in the population was estimated using statistical simulation that accounted for the sampling design. RSV G and F proteins and influenza hemagglutinin genes were sequenced. 2385 children with ALRI were enrolled, 519 were randomly selected for viral testing. One or more viruses were detected in 303/519 children (58.4%). RSV-A was detected in 237 and RSV-B in seven. The expected incidence of ALRI associated with RSV, PIV or influenza was 140 cases (95% CI, 131-149) per 1000 person-years; RSV incidence was 112 cases (95% CI, 102-122) per 1000 person-years. Multiple strains of RSV and influenza circulated during the year. RSV circulated throughout most of the year and was associated with eight times the number of ALRI cases compared to PIV or IV. Gambian RSV viruses were closely related to viruses detected in other continents. An effective RSV vaccination strategy could have a major impact on the burden of ALRI in this setting.
Identifiants
pubmed: 31784567
doi: 10.1038/s41598-019-54059-4
pii: 10.1038/s41598-019-54059-4
pmc: PMC6884537
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
17965Subventions
Organisme : Medical Research Council
ID : MC_UU_00026/2
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_UP_A900_1122
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/R005990/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/R005990/2
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_PC_17221
Pays : United Kingdom
Références
Scand J Infect Dis. 2006;38(8):690-5
pubmed: 16857616
Clin Infect Dis. 2020 Jan 1;70(1):59-66
pubmed: 30810160
Lancet Infect Dis. 2016 Aug;16(8):e153-63
pubmed: 27317449
Clin Infect Dis. 2017 Aug 15;65(4):604-612
pubmed: 28605562
PLoS Med. 2012 Jan;9(1):e1001161
pubmed: 22272192
J Clin Microbiol. 2009 Nov;47(11):3439-43
pubmed: 19726607
J Infect Dis. 2018 Jul 13;218(4):572-580
pubmed: 29617879
PLoS One. 2018 Jul 24;13(7):e0200319
pubmed: 30040837
Bull World Health Organ. 2004 Dec;82(12):914-22
pubmed: 15654405
Wellcome Open Res. 2018 Jul 25;3:89
pubmed: 30175247
Arch Virol. 2014 May;159(5):1089-98
pubmed: 24297488
PLoS Pathog. 2014 Apr 24;10(4):e1004016
pubmed: 24763387
Vaccine. 2013 Apr 18;31 Suppl 2:B61-72
pubmed: 23598494
Vaccine. 2013 Dec 17;32(1):165-79
pubmed: 24331112
Clin Infect Dis. 2017 Jun 15;64(suppl_3):S337-S346
pubmed: 28575373
Vaccine. 2017 Jan 11;35(3):461-468
pubmed: 27692522
J Clin Virol. 2014 Jul;60(3):309-12
pubmed: 24875136
Lancet. 2017 Dec 17;388(10063):3027-3035
pubmed: 27839855
Lancet. 2017 Sep 2;390(10098):946-958
pubmed: 28689664
PLoS One. 2011;6(6):e21610
pubmed: 21738731
Lancet Infect Dis. 2016 Jun;16(6):703-711
pubmed: 26897105
J Infect Dis. 2012 Nov 15;206(10):1532-41
pubmed: 22966119
Emerg Infect Dis. 2019 Jun;25(6):1127-1135
pubmed: 31107230
PLoS One. 2016 Jun 17;11(6):e0157163
pubmed: 27315120
Med J Aust. 2019 Jun;210(10):447-453
pubmed: 31066061
PLoS One. 2018 Sep 10;13(9):e0203788
pubmed: 30199549
Virus Evol. 2018 Sep 24;4(2):vey027
pubmed: 30271623
J Infect Dis. 2018 Aug 24;218(7):1045-1053
pubmed: 29722817
J Virol. 2015 Apr;89(7):3444-54
pubmed: 25609811
PLoS One. 2015 Mar 20;10(3):e0120098
pubmed: 25793751
Sci Rep. 2017 Sep 25;7(1):12232
pubmed: 28947776
Int J Infect Dis. 2018 Oct;75:18-25
pubmed: 30118916
Curr Top Microbiol Immunol. 2013;372:259-84
pubmed: 24362694
Clin Infect Dis. 2009 Nov 1;49(9):1341-9
pubmed: 19788358
Lancet Infect Dis. 2017 Sep;17(9):965-973
pubmed: 28601421
J Clin Microbiol. 2011 Jun;49(6):2311-3
pubmed: 21450959
Nat Microbiol. 2017 Jan 30;2:16271
pubmed: 28134924